IRIS - Res&Arch Institutional Research Information System - Research & Archive

FALINI, Brunangelo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.348
EU - Europa 5.869
AS - Asia 1.256
Continente sconosciuto - Info sul continente non disponibili 9
SA - Sud America 8
AF - Africa 5
OC - Oceania 5
Totale 13.500
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.309
IE - Irlanda 1.332
IT - Italia 1.234
UA - Ucraina 1.140
SE - Svezia 986
HK - Hong Kong 464
VN - Vietnam 460
FI - Finlandia 312
RU - Federazione Russa 241
DE - Germania 233
CN - Cina 208
GB - Regno Unito 145
TR - Turchia 58
FR - Francia 56
CH - Svizzera 49
BE - Belgio 33
CA - Canada 33
UZ - Uzbekistan 26
AT - Austria 25
PL - Polonia 21
NL - Olanda 20
GR - Grecia 14
LB - Libano 12
CZ - Repubblica Ceca 10
EU - Europa 8
SG - Singapore 8
JP - Giappone 6
BR - Brasile 5
IN - India 5
RO - Romania 5
ES - Italia 4
KR - Corea 4
CI - Costa d'Avorio 3
IL - Israele 3
MX - Messico 3
NZ - Nuova Zelanda 3
AU - Australia 2
BG - Bulgaria 2
EC - Ecuador 2
PA - Panama 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BO - Bolivia 1
EE - Estonia 1
GT - Guatemala 1
IM - Isola di Man 1
KH - Cambogia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MA - Marocco 1
NO - Norvegia 1
PT - Portogallo 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 13.500
Salva come PNG Salva come JPEG
Città #
Chandler 1.498
Dublin 1.332
San Mateo 712
Jacksonville 607
Perugia 515
Hong Kong 463
Dong Ket 460
Altamura 333
Medford 301
Princeton 296
Wilmington 246
Lawrence 232
Ann Arbor 201
Andover 197
Beijing 126
Des Moines 95
Saint Petersburg 85
Norwalk 67
Helsinki 63
Ashburn 59
Izmir 57
Woodbridge 49
Falls Church 47
Shanghai 47
Los Angeles 45
New York 41
San Paolo di Civitate 41
Redmond 35
Brussels 33
Boardman 31
Ottawa 28
Redwood City 27
Houston 24
Rome 22
Moscow 20
Dearborn 19
Foligno 18
Auburn Hills 16
Ficarazzi 13
Terni 11
Den Haag 10
Chicago 9
Philadelphia 7
San Diego 7
Tappahannock 7
Amelia 6
Guangzhou 6
Lappeenranta 6
Lausanne 6
Collazzone 5
Florence 5
Frankfurt am Main 5
Nanning 5
Simi Valley 5
Singapore 5
Verona 5
Amsterdam 4
Duncan 4
Frankfurt Am Main 4
Kraków 4
London 4
Madrid 4
Milan 4
Tivoli 4
Tokyo 4
Abidjan 3
Assisi 3
Aurora 3
Basel 3
Bucharest 3
Cambridge 3
Edinburgh 3
Fairfield 3
Fremont 3
Gradara 3
Nürnberg 3
Paris 3
Prata Di Pordenone 3
Scafa 3
Seoul 3
Bacoli 2
Belgioioso 2
Bologna 2
Brasília 2
Campobasso 2
Changsha 2
Chaoyang 2
Cornedo Vicentino 2
Essen 2
Falkenstein 2
Guayaquil 2
Hangzhou 2
Hefei 2
Ludwigshafen 2
Macerata 2
Mexico City 2
Montreal 2
Nanjing 2
Narni 2
Nepi 2
Totale 8.732
Salva come PNG Salva come JPEG
Nome #
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. 101
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells 97
Anaplastic large cell lymphoma: changes in the World Health Organization classification and perspectives for targeted therapy. 94
Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biological and clinical features 90
Anaplastic lymphoma kinase expression as a marker of malignancy. Application to a case of anaplastic large cell lymphoma with huge granulomatous reaction. 89
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification 89
Acute leukaemia immunophenotyping in bone-marrow routine sections. 88
Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity? 86
Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma 85
Anaplastic large cell lymphoma: pathological, molecular and clinical features. 83
Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice 82
Germline NPM1 mutations lead to altered rRNA 2′-O-methylation and cause dyskeratosis congenita 81
Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias. 80
The EML4-ALK transcript but not the fusion protein can be expressed in reactive and neoplastic lymphoid tissues. 79
Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives. 78
Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance 78
Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification 78
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma 78
Primay large B-cell lymphoma (PLBCL) of the retroperitoneum: a heterogeneous group of neoplasms, some of which mimic PLBCL of the mediastinum. 76
AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features 76
A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma. 75
Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice. 75
A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells 74
ARSENIC TRIOXIDE AND ALL-TRANS-RETINOIC ACID TARGET NPM1 MUTANT ONCOPROTEIN LEVELS AND INDUCE APOPTOSIS IN NPM1-MUTATED AML CELLS 74
MONOCLONAL ANTIBODIES PG-B6a AND PG-B6p RECOGNIZE, RESPECTIVELY, A HIGHLY CONSERVED AND A FORMOL-RESISTANT EPITOPE ON THE HUMAN BCL-6 PROTEIN AMINO-TERMINAL REGION. 72
Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications. 72
NPM1 deletion is associated with gross chromosomal rearrangements in leukemia 72
Genomics of Hairy cell leukemia 72
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. 71
Immunophenotypic and genotypic markers of follicular center cell neoplasia in diffuse large B-cell lymphomas 70
Minimal residual disease levels assessed by NPM1 mutation specific RQ-PCR provide important prognostic information in AML. 70
Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease 70
Nucleophosmin regulates the stability and transcriptional activity of p53. 69
Fludarabine Plus Mitoxantrone With and Without Rituximab Versus CHOP With and Without Rituximab As Front-Line Treatment for Patients With Follicular Lymphoma. 69
TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations. 69
Simultaneous occurrence of acute myeloid leukaemia with mutated nucleophosmin (NPM1) in the same family. 69
Antitumor activity of anti-CD30 immunotoxin (Ber-H2/saporin) in vitro and in severe combined immunodeficiency disease mice xenografted with human CD30+ anaplastic large-cell lymphoma. 69
Aggressive lymphomas: a convenient concept or an anatomo-pathological reality? 68
Detection of normal and chimeric nucleophosmin in human cells. 68
Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy 68
CHARACTERIZATION OF A NEW MONOCLONAL ANTIBODY (PG-M3) DIRECTED AGAINST THE AMINOTERMINAL PORTION OF THE PML GENE PRODUCT: IMMUNOCYTOCHEMICAL EVIDENCE FOR HIGH EXPRESSION OF PML PROTEINS ON ACTIVATED MACROPHAGES, ENDOTHELIAL CELLS, AND EPITHELIA 67
Any role for the nucleophosmin (NPM1) gene in myelodysplastic syndromes and acute myeloid leukemia with chromosome 5 abnormalities? 67
Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1). 67
Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT) 66
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 66
[The Haemolymphopathology Italian Group (H.I.G.): an essential resource for the new technical and organization problems troubling modern haemolymphopathology diagnostics] 65
Aberrant hypermutation of PIM1, PAX5, RhoH/TTF and cMYC in nodular lymphocyte predominance Hodgkin's disease 65
NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia. 65
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia 65
Diversity of genomic breakpoints in TFG-ALK translocations in anaplastic large cell lymphomas: identification of a new TFG-ALK(XL) chimeric gene with transforming activity 64
Nucleophosmin is required for DNA integrity and p19Arf protein stability. 64
NPM1 AND FLT3-ITD MUTATIONS SINERGISTICALLY INDUCE GATA1 EPIGENETIC SILENCING IN A AML MOUSE MODEL 63
Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma 63
Acute Myeloid Leukemia with mutated nucleophosmin (NPM1). Any hope for a targeted therapy? 62
NPM1-mutated AML: targeting by disassembling 62
Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma. 62
A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1) 62
Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases 60
Bcl-6 protein expression in normal and neoplastic lymphoid tissues. 60
Mutational landscape of AML with normal cytogenetics: biological and clinical implications 60
Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: a shared clonal origin 60
Dactinomycin in NPM1-Mutated Acute Myeloid Leukemia 60
T regulatory cell separation for clinical application. 60
Mutant NPM1 Maintains the Leukemic State through HOX Expression 60
Immune response to the ALK oncogenic tyrosine kinase in patients with anaplastic large-cell lymphoma. 59
Evolving concepts in the pathogenesis of hairy-cell leukaemia. 59
Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia 59
IL-17-producing CD4-CD8- T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjogren's syndrome. 59
GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutations 59
Exon-12 nucleophosmin (NPM) mutation and aberrant cytoplasmic expression of NPM protein in leukemia cell line OCI-AML3 58
The NPM1 wild-type OCI-AML2 and the NPM1-mutated OCI-AML3 cell lines carry DNMT3A mutations. 58
How Adoptive Immunotherapy with Conventional T and Regulatory T Cells Exerts a Gvl Effect without GvHD, after Haploidentical Hematopoietic Transplantation 58
BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activity 58
A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: Final results of the GIMEMA LAL 0904 study 58
Prognostic impact of genetic characterization in the GIMEMA LAM99P study for newly diagnosed adult AML. Relevance of combined analysis of conventional karyotyping, FLT3 and NPM mutational status 57
Cuplike nuclei (prominent nuclear invaginations) in acute myeloid leukemia are highly associated with FLT3 internal tandem duplication and NPM1 mutation. 57
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia 57
Coinvolgimento cutaneo da leucosi acuta mieloide con dislocazione citoplasmatica di nucleofosmina (sarcoma mieloide NPMc+) 57
BRAF mutations in hairy-cell leukemia. 57
A powerful molecular synergy between mutant Nucleophosmin and Flt3-ITD drives acute myeloid leukemia in mice. 57
High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1-Mutated AML 57
Human immunodeficiency virus-associated Hodgkin's disease derives from post-germinal center B cells. 57
Gene expression analysis of peripheral T-cell lymphoma not otherwise specified reveals the existance of two subgroups related to different cellular counterparts and recurrent PDGFRA deregulation 56
Cytoplasmic mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia. 56
Aberrant cytoplasmic expression of C-terminal-truncated NPM leukaemic mutant is dictated by tryptophans loss and a new NES motif. 56
Clustering of genomic breakpoints at the MLL locus in therapy-related acute leukemia with t(4;11)(q21;q23). 56
Denaturing high-performance liquid chromatography: a valid approach for identifying NPM1 mutations in Acute Myeloid Leukemia 56
Coinvolgimento cutaneo da leucosi acuta mieloide con dislocazione citoplasmatica di nucleofosmina (sarcoma mieloide NPMc+) 55
Antigen retrieval techniques in immunohistochemistry: comparison of different methods 55
Treating two concurrent B-cell and T-cell lymphoid neoplasms with alemtuzumab monotherapy 53
A case of JAK2 V617F-positive myelodisplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 53
IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas. 53
Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia. 53
Beta-HCG aberrant expression in primary mediastinal large B-cell lymphoma. 53
Mechanism of altered nucleo-cytoplasmic traffic of nucleophosmin in acute myelogenous leukemia carrying exon12 NPM mutations (NPMc plus AML) 53
ARPIR: automatic RNA-Seq pipelines with interactive report 53
Randomized trial of 8-week versus 12-week VNCOP-B plus G-CSF regimens as front-line treatment in elderly aggressive non-Hodgkin's lymphoma patients 52
Cellular localization and tissue distribution of PML proteins as defined by a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product. Preferential expression in postmitotic cells. 52
Diffuse large B-cell lymphoma (DLBCL), anaplastic variant. report on a problematic case primarily arising in the stomach 52
Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AML. 52
Totale 6.629
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.652
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.652
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201997 0 0 0 0 0 0 0 0 0 0 86 11
2019/20201.112 29 15 149 13 147 26 155 41 195 164 28 150
2020/20212.805 10 169 115 169 732 202 179 56 323 102 228 520
2021/20222.955 70 548 79 184 108 41 30 782 71 161 452 429
2022/20234.789 332 867 47 405 383 536 6 218 1.712 61 165 57
2023/20241.149 128 193 102 48 18 20 406 30 151 53 0 0
Totale 14.334